Indoleamine 2, 3-Dioxygenase and B7-H1 Expressions As Prognostic and Follow-Up Markers in Human Pancreatic Carcinoma

Liancai Wang,Qingyong Ma,Deyu Li,Senmao Mu,Yong Li,Yafeng Wang,Pengfei Shi,Haibo Yu,Chunhui Gao,Kun Guo,Zhuoli Zhang
DOI: https://doi.org/10.1016/j.prp.2018.02.016
IF: 3.309
2018-01-01
Pathology - Research and Practice
Abstract:This study was to test hypotheses that indoleamine 2, 3-dioxygenase and B7-H1 expressions can be used as prognostic markers in human pancreatic carcinoma (PC). Ninety-five patients were recruited who had undergone radical surgical resection for PC. IDO and B7-H1 expressions in PC tissue specimens were evaluated by immunohistochemistry (IHC) techniques. The clinical and pathological features of these specimens were analyzed. IDO positive, B7-H1 positive, and combined IDO/B7-H1 positive tumors exhibited significant correlations with lymphocytic infiltration, perineural invasion, TNM status, and pathologic grade (p < .05), which tended to show strong correlations with malignant progression of PC. Also, IDO correlated with diabetes mellitus (DM) and HAD scale and B7-H1 correlated with smoke (p < .05). In addition, the correlation analysis indicated that IDO had a positive correlation with B7-H1 (p < .05). Moreover, the results showed that a combination of IDO and B7-H1 expressions could serve as independent prognostic marker after adjusting by Cox proportional hazards regression models (p < .05). IDO and B7-H1 expressions were observed in patient with PC tissues and are important markers for PC malignant progression. A combination of IDO and B7-H1 expression can be served as an independent prognostic marker for PC.
What problem does this paper attempt to address?